Library / regulatory-reference
Spain: Spanish Agency of Medicines and Medical Devices (AEMPS)
Audience: administrators-policy, researchers-scientists ยท Review state: published
The national authority
AEMPS, the Spanish Agency of Medicines and Medical Devices, is Spain's national regulator for medicines, medical devices, cosmetics and related products, operating under the Ministry of Health.
Spain's market sits inside the European single market, and the agency covers human and veterinary medicines as well as devices and personal-care products.
How products enter the market
Medicines require marketing authorization through national or European procedures after evaluation of quality, safety and efficacy, and manufacturers are licensed and inspected.
Post-market work includes pharmacovigilance, device vigilance, supply-shortage management and public safety alerts to professionals and patients.
Regional and international role
The agency is an active member of the European regulatory network and contributes to joint assessments and inspections.
Its broad product scope within one agency makes it a clear example of an integrated health-products regulator.
Using this profile
The authority publishes regulations, registers and alerts in Spanish and English through its official portal, which is the primary source for current rules and listed in this profile's internal reference record.
For cross-country comparison: Spain illustrates the integrated regulator: medicines, devices and related products under one agency.
Limitations
Educational profile of a national regulatory system, current as of drafting. It simplifies routes and classes and is not legal, regulatory, or clinical advice. Filing and compliance decisions must be confirmed against the authority's current published rules and, where needed, professional regulatory counsel.